Share-based Payment Arrangement, Expense in USD of AbCellera Biologics Inc. from 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
AbCellera Biologics Inc. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from 2019 to Q3 2025.
  • AbCellera Biologics Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $13.9M, a 19.1% decline year-over-year.
  • AbCellera Biologics Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $58.1M, a 15.5% decline year-over-year.
  • AbCellera Biologics Inc. annual Share-based Payment Arrangement, Expense for 2024 was $67.6M, a 5.29% increase from 2023.
  • AbCellera Biologics Inc. annual Share-based Payment Arrangement, Expense for 2023 was $64.2M, a 29.7% increase from 2022.
  • AbCellera Biologics Inc. annual Share-based Payment Arrangement, Expense for 2022 was $49.5M, a 61.5% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

AbCellera Biologics Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $58.1M $13.9M -$3.27M -19.1% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025
Q2 2025 $61.4M $14.2M -$3.57M -20.1% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 $65M $14.8M -$2.62M -15.1% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025
Q4 2024 $67.6M $15.2M -$1.22M -7.44% 01 Oct 2024 31 Dec 2024 10-K 27 Feb 2025
Q3 2024 $68.8M $17.2M +$1.3M +8.21% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025
Q2 2024 $67.5M $17.8M +$1.38M +8.43% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025
Q1 2024 $66.1M $17.4M +$1.94M +12.5% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025
Q4 2023 $64.2M $16.4M +$3.13M +23.5% 01 Oct 2023 31 Dec 2023 10-K 27 Feb 2025
Q3 2023 $61.1M $15.9M +$4.11M +35% 01 Jul 2023 30 Sep 2023 10-Q 04 Nov 2024
Q2 2023 $57M $16.4M +$4.29M +35.4% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024
Q1 2023 $52.7M $15.5M +$3.18M +25.9% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024
Q4 2022 $49.5M $13.3M +$4.28M +47.4% 01 Oct 2022 31 Dec 2022 10-K 27 Feb 2025
Q3 2022 $45.2M $11.8M +$4.05M +52.5% 01 Jul 2022 30 Sep 2022 10-Q 02 Nov 2023
Q2 2022 $41.2M $12.1M +$3.64M +43% 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023
Q1 2022 $37.5M $12.3M +$6.86M +126% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023
Q4 2021 $30.6M $9.04M +$4.42M +95.6% 01 Oct 2021 31 Dec 2021 10-K 20 Feb 2024
Q3 2021 $26.2M $7.71M +$5.77M +299% 01 Jul 2021 30 Sep 2021 10-Q 08 Nov 2022
Q2 2021 $20.5M $8.47M +$7.87M +1298% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022
Q1 2021 $12.6M $5.43M +$4.19M +339% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022
Q4 2020 $8.4M $4.62M 01 Oct 2020 31 Dec 2020 10-K 21 Feb 2023
Q3 2020 $1.93M 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021
Q2 2020 $606K 01 Apr 2020 30 Jun 2020 10-Q 13 Aug 2021
Q1 2020 $1.24M 01 Jan 2020 31 Mar 2020 10-Q 14 May 2021

AbCellera Biologics Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $67.6M +$3.4M +5.29% 01 Jan 2024 31 Dec 2024 10-K 27 Feb 2025
2023 $64.2M +$14.7M +29.7% 01 Jan 2023 31 Dec 2023 10-K 27 Feb 2025
2022 $49.5M +$18.8M +61.5% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025
2021 $30.6M +$22.2M +265% 01 Jan 2021 31 Dec 2021 10-K 20 Feb 2024
2020 $8.4M +$7.51M +843% 01 Jan 2020 31 Dec 2020 10-K 21 Feb 2023
2019 $890K 01 Jan 2019 31 Dec 2019 10-K 25 Feb 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.